跳至主要内容
临床试验/ACTRN12615000970549
ACTRN12615000970549已完成未知

Response of Patients with Neuromuscular Disease to Hyperoxia and Normoxia, as Measured by Carbon Dioxide Levels: Study 2

Janine Pilcher0 个研究点目标入组 24 人开始时间: 2015年9月16日最近更新:
适应症

试验速览

阶段
未知
状态
已完成
发起方
入组人数
24

研究概览

简要总结

暂无简介。

研究设计

研究类型
Interventional
分配方式
Randomised controlled trial
主要目的
Treatment
盲法
Blinded (masking used)

入排标准

年龄范围
14 Years 至 o limit(—)
性别
All

入选标准

  • Diagnosis of neuromuscular disease with a greater than or equal to 10% drop in vital capacity from standing to lying, or a sniff nasal inspiratory pressure under the lower limit (above which lie 95% of healthy subjects), based on work by Uldry and Fitting (Thorax 1995;50(4)).
  • Kyphoscoliosis with an FVC <65% predicted.

排除标准

  • Baseline transcutaneous carbon dioxide of greater than or equal to 60mmHg
  • Diagnosis of chronic obstructive pulmonary disease
  • FEV1:FVC ratio less than or equal to 70% (if participant able to perform forced spirometry)
  • Obesity (with a body mass index of greater than or equal to 40)
  • Any other condition which, at the investigator's discretion, is believed may present a safety risk or impact the feasibility of the study or the study results.

研究者

发起方
Janine Pilcher

相似试验

High Concentration Oxygen in Neuromuscular Disease:... | 临床试验